Growth and differentiation factor 15 (GDF15) is a member of the transforming growth factor‐β
(TGF‐β) superfamily. GDF15 has been linked with several metabolic syndrome pathologies …

Type 2 diabetes mellitus (T2DM) is a chronic endocrine disorder due to the reduction of
insulin sensitivity and relative deficiency of insulin secretion. Growth differentiation factor 15 …

Human growth differentiation factor 15 (GDF-15) is a widely distributed protein that has
shown to play multiple roles in both physiological and pathological conditions. In healthy …

There is no literature available about the growth differentiation factor-15 (GDF-15) biomarker
in combination with mitochondrial DNA (mtDNA) deletions in insulin resistance (IR), and …

Mounting evidence points to a link between growth differentiation factor-15 (GDF15)
expression and the onset and progression of diabetes mellitus. However, the exact role of …

Background: The great saphenous vein (GSV) is the most commonly used conduit for
coronary arterial bypass graft. However, the status of the GSV, including metabolic …

Abstract Glucagon‐like peptide‐1 receptor (GLP‐1R) agonists induce weight loss in patients
with type 2 diabetes mellitus (T2DM), but the underlying mechanism is unclear. Recently, the …

Diabetes has become a serious public health crisis, presenting significant challenges to
individuals worldwide. As the largest organ in the human body, skeletal muscle is a …

Objective Growth differentiation factor 15 (GDF15), a stress related cytokine, was recently
identified as a novel satiety signal acting via the GFRAL receptor located in the hindbrain …

Aim/hypothesis Growth/differentiation factor 15 (GDF15) is a therapeutic target for a variety
of metabolic diseases, including type 1 diabetes (T1D). However, the nausea caused by …